Cardiovascular risk and body-fat abnormalities in HIV-infected adults [4] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 16, 2005, Pages 1721-1722

  Behrens, Georg M N ^a   Grinspoon, Steven ^b   Carr, Andrew ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; LIPID;

BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AREA UNDER CURVE; CORONARY DISEASE; HIV INFECTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; PRACTICE GUIDELINES; RISK;

EID: 17244372383     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200504213521620     Document Type: Letter

References (0)